Cellbion Co., Ltd
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
308430 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 종로구 대학로 103 서울대학교 암연구소 6층, 종로구
- Website:
- http://www.cellbion.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cellbion Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the research, development, and manufacturing of radiopharmaceuticals. The company focuses on advancing Radioligand Therapy (RLT) and antibody-based treatments to address unmet medical needs, particularly in oncology. Its pipeline includes diagnostic imaging agents for PET CT and therapeutic drugs, with a key program targeting Prostate-Specific Membrane Antigen (PSMA) for the diagnosis and therapy of prostate cancer. Cellbion operates a GMP-certified facility for the production of liquid and lyophilized injectable products, supporting both clinical trials and commercial supply.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Cellbion Co., Ltd and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all Cellbion Co., Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Cellbion Co., Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
